Grand Pharmaceutical Group (FRA:MX6A) Other Long Term Assets : €1,145 Mil (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Grand Pharmaceutical Group Other Long Term Assets?

Grand Pharmaceutical Group's other long-term assets for the quarter that ended in Dec. 2024 was €1,145 Mil.

Grand Pharmaceutical Group's quarterly other long-term assets increased from Dec. 2023 (€1,088 Mil) to Jun. 2024 (€1,110 Mil) and increased from Jun. 2024 (€1,110 Mil) to Dec. 2024 (€1,145 Mil).

Grand Pharmaceutical Group's annual other long-term assets declined from Dec. 2022 (€1,152 Mil) to Dec. 2023 (€1,088 Mil) but then increased from Dec. 2023 (€1,088 Mil) to Dec. 2024 (€1,145 Mil).

Grand Pharmaceutical Group Other Long Term Assets Historical Data

The historical data trend for Grand Pharmaceutical Group's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Grand Pharmaceutical Group Other Long Term Assets Chart

Grand Pharmaceutical Group Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Long Term Assets

Get a 7-Day Free Trial

728.24

1,006.56

1,151.92

1,088.22

1,144.65

Grand Pharmaceutical Group Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Other Long Term Assets	Get a 7-Day Free Trial															1,151.92	1,114.31	1,088.22	1,109.50	1,144.65

Grand Pharmaceutical Group Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Grand Pharmaceutical Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Grand Pharmaceutical Group Ltd (FRA:MX6A) » Definitions » Other Long Term Assets

Traded in Other Exchanges

00512:Hong Kong

Address

99 Queen's Road, Units 3302, 33rd Floor, The Center, Central, Hong Kong, HKG

Website

https://www.grandpharma.cn/en

Grand Pharmaceutical Group Ltd, is an international pharmaceutical company of technological innovation. Its core businesses cover three areas: nuclear medicine anti-tumor diagnosis and treatment, cerebro-cardiovascular precision interventional diagnosis and treatment technology, pharmaceutical technology, and biotechnology. Based on the pharmaceutical and biological industries, the Group focuses on the needs of patients, and technological innovation as the driving force Geographically, it derives a majority of its revenue from the PRC and also has a presence in America; Europe; and Asia other than the PRC, and others.

Grand Pharmaceutical Group Headlines

No Headlines